Renovaro BiosciencesRENB 
$0.640.31%24h
0.31%24h
Global rank26075
Market cap$36.01M
Change 7d10.34%
YTD Performance-79.68%
SP500 benchmarkUnderperform
P/E-0.90
P/S0
Revenue$0
Earnings-$39.68M
Dividend yield-
Main Sector
Healthcare
Renovaro Biosciences RENB Total Debt
RENB Total Debt in 2022: $775.59K
According to Renovaro Biosciences latest financial reports the total debt is $775.59K, an decrease of -86.06% to 2022. At the end of 2022 company had $5.56M total debt. This figure represents the debts and financial obligations that Renovaro Biosciences combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Renovaro Biosciences RENB Total Debt History from 2023 to 2022
-
Value:-
RENB Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $775.59K | -86.06% |
| 2022 | $5.56M | -20.74% |
| 2021 | $7.02M | -4.02% |
| 2020 | $7.31M | - |
View the Top Total Debt Stocks 
